open access

Online first
Editorial
Published online: 2023-01-27
Get Citation

The Sisyphean task of VT mapping and ablation in structural heart disease

Michael Lloyd1, Vardhmaan Jain2
DOI: 10.33963/KP.a2023.0029
Affiliations
  1. Section of Cardiac Electrophysiology, Emory University Hospital, Atlanta, GA, United States
  2. Section of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States

open access

Online first
Editorial
Published online: 2023-01-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

The Sisyphean task of VT mapping and ablation in structural heart disease

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Editorial

Published online

2023-01-27

Page views

25

Article views/downloads

28

DOI

10.33963/KP.a2023.0029

Authors

Michael Lloyd
Vardhmaan Jain

References (6)
  1. Cronin E, Bogun F, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. EP Europace. 2019; 21(8): 1143–1144.
  2. Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016; 375(2): 111–121.
  3. Arenal Á, Ávila P, Jiménez-Candil J, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022; 79(15): 1441–1453.
  4. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357(26): 2657–2665.
  5. Karkowski G, Ząbek A, Szotek M, et al. et al.. Radiofrequency catheter ablation of ventricular tachycardia using combined endocardial techniques in patients with structural heart disease improves procedural effectiveness and reduces arrhythmia episodes. Kardiol Pol. 2022 [Epub ahead of print]: Dec.
  6. Sauer WH, Zado E, Gerstenfeld EP, et al. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2010; 7(1): 9–14.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl